Correlation Between Bioatla and Eliem Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bioatla and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioatla and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioatla and Eliem Therapeutics, you can compare the effects of market volatilities on Bioatla and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioatla with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioatla and Eliem Therapeutics.

Diversification Opportunities for Bioatla and Eliem Therapeutics

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between Bioatla and Eliem is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Bioatla and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Bioatla is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioatla are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Bioatla i.e., Bioatla and Eliem Therapeutics go up and down completely randomly.

Pair Corralation between Bioatla and Eliem Therapeutics

Given the investment horizon of 90 days Bioatla is expected to under-perform the Eliem Therapeutics. In addition to that, Bioatla is 1.46 times more volatile than Eliem Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.05 per unit of volatility. If you would invest  320.00  in Eliem Therapeutics on September 15, 2024 and sell it today you would lose (11.00) from holding Eliem Therapeutics or give up 3.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy71.43%
ValuesDaily Returns

Bioatla  vs.  Eliem Therapeutics

 Performance 
       Timeline  
Bioatla 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Bioatla is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Bioatla and Eliem Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bioatla and Eliem Therapeutics

The main advantage of trading using opposite Bioatla and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioatla position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.
The idea behind Bioatla and Eliem Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios